Brigit Biofarmaka Teknologi Tbk. vs Paramita Bangun Sarana Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume), while Paramita Bangun Sarana Tbk. trades at Rp870 (market cap 2.73T, 2.44M 24h volume). The key difference: Paramita Bangun Sarana Tbk. is far larger — about 16.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Paramita Bangun Sarana Tbk. is more actively traded (2.44M versus 43.9K). Which is the better fit depends on your goals.
| OBAT | PBSA | |
|---|---|---|
Market Cap | 164.65B | 2.73T |
Volume | 43.9K | 2.44M |
Lot | 439 | 24.43K |
Turnover | 10.6M | 2.09B |
Average Price | 241.43 | 855.66 |
Value | 10.6M | 2.09B |
Indicative Equilibrium Price | 238 | 890 |
Indicative Equilibrium Volume | 100 | 801 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT. Paramita Bangun Sarana Tbk (the Company) was established based on the Notarial Deed No. 33 of Lenny Janis Ishak, S.H., dated November 27, 2002.
Read more on PBSA →